A novel FAM20C mutation causing hypophosphatemic osteomalacia with osteosclerosis (mild Raine syndrome) in an elderly man with spontaneous osteonecrosis of the knee.


Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 13 04 2018
accepted: 12 08 2018
pubmed: 29 8 2018
medline: 20 8 2019
entrez: 29 8 2018
Statut: ppublish

Résumé

Raine syndrome is characterized by FGF23-mediated hypophosphatemic osteomalacia with osteosclerosis caused by mutations in the FAM20C gene. We report a case of a 72-year-old man who presented with rapid progressive spontaneous osteonecrosis of the knee (SONK). A full osteologic assessment including dual energy X-ray absorptiometry (DXA), high-resolution peripheral quantitative computed tomography (HR-pQCT), and serum analyses revealed a high bone mass in the lumbar spine and hip (DXA T-score + 7.5 and + 4.7/+4.2) with increased bone microstructural parameters in the distal radius and tibia (BV/TV 127%, 140% of the age-matched mean, respectively), as well as a low bone turnover state. Phosphate levels were low due to renal phosphate wasting and high FGF23 levels (126.5 pg/ml, reference range 23.2-95.4 pg/ml). Using gene panel sequencing, we identified a novel FAM20C heterozygous missense mutation in combination with a homozygous duplication that potentially alters splicing. Taken together, this is the first case of mild Raine syndrome with spontaneous osteonecrosis of the knee, phosphate wasting, and a pronounced trabecular high bone mass phenotype.

Identifiants

pubmed: 30151622
doi: 10.1007/s00198-018-4667-6
pii: 10.1007/s00198-018-4667-6
doi:

Substances chimiques

Extracellular Matrix Proteins 0
FGF23 protein, human 0
Fibroblast Growth Factor-23 7Q7P4S7RRE
Casein Kinase I EC 2.7.11.1
FAM20C protein, human EC 2.7.11.1

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

685-689

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : Detection and Individualized Management of Early Onset Osteoporosis (DIMEOS)

Références

Am J Med Genet. 1992 Jul 15;43(5):860-4
pubmed: 1642277
Am J Hum Genet. 2007 Nov;81(5):906-12
pubmed: 17924334
Knee Surg Sports Traumatol Arthrosc. 2013 Feb;21(2):340-5
pubmed: 22534975
Science. 2012 Jun 1;336(6085):1150-3
pubmed: 22582013
PLoS One. 2012;7(8):e42988
pubmed: 22900076
J Bone Miner Res. 2013 Jun;28(6):1378-85
pubmed: 23325605
Semin Nephrol. 2013 Mar;33(2):143-57
pubmed: 23465501
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5520-5
pubmed: 24706917
Bone. 2014 Oct;67:56-62
pubmed: 24982027
Eur J Med Genet. 2014 Sep;57(9):536-42
pubmed: 25019372
Bone. 2014 Oct;67:145-51
pubmed: 25026495
BMC Med Genet. 2015 Feb 21;16:8
pubmed: 25928877
Cell. 2015 Jun 18;161(7):1619-32
pubmed: 26091039
J Med Genet. 1989 Dec;26(12):786-8
pubmed: 2614802
J Bone Miner Res. 2016 Nov;31(11):2041-2047
pubmed: 27192388
Eur J Med Genet. 2016 Nov;59(11):577-583
pubmed: 27667191
J Bone Miner Res. 2017 Apr;32(4):757-769
pubmed: 27862258
Osteoporos Int. 2017 Jun;28(6):1805-1816
pubmed: 28314897
Gene Ther. 2017 Sep;24(9):529-533
pubmed: 28644430
Clin Endocrinol (Oxf). 1995 Sep;43(3):373-82
pubmed: 7586609

Auteurs

T Rolvien (T)

Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestr. 59, 22529, Hamburg, Germany.
Department of Orthopedics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
National Bone Board, Martin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

U Kornak (U)

National Bone Board, Martin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin-Brandenburg School for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany.
FG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.

T Schinke (T)

Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestr. 59, 22529, Hamburg, Germany.
National Bone Board, Martin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

M Amling (M)

Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestr. 59, 22529, Hamburg, Germany.
National Bone Board, Martin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

R Oheim (R)

Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestr. 59, 22529, Hamburg, Germany. r.oheim@uke.de.
National Bone Board, Martin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. r.oheim@uke.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH